However, while a decreasing trend in β-MHC expression was observed following treatment, it did not reach statistical significance ( Figures 6G,H ).
← all excerpts
Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection.
1
—
—